sequenom inc (SQNM:NASDAQ GS)
Paul V. Maier M.B.A.
Chief Financial Officer, Sequenom Inc.
|Age||Total Calculated Compensation||This person is connected to 28 board members in 3 different organizations across 8 different industries.|
See Board Relationships
As of Fiscal Year 2012
Mr. Paul V. Maier, M.B.A. has been the Chief Financial Officer of Sequenom Inc. since June 2010. Mr. Maier has been an Independent Financial Consultant since February 2007. He has over 20 years of experience as a senior executive in biotechnology and pharmaceutical companies. He served as Chief Financial Officer and Senior Vice President at Organon Pharmaceuticals USA, Inc. He served as a Consultant from October 2009 to November 10, 2009 and Interim Chief Financial Officer ...
3595 John Hopkins CourtPhone: 858-202-9000
San Diego, California 92121
Board Members Memberships*
Former Director, Chairman of Audit Committee and Member of Nominating and Corporate Governance Committee
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Governance Committee
Former Director, Chairman of Audit Committee and Chairman of Compensation Committee
Director, Chairman of Audit Committee, Member of Special Committee and Member of Finance & Transactions Committee
Director, Chairman of Audit Committee and Member of Corporate Governance/Nominating Committee
Pennsylvania State University
|Hany Massarany||Chief Executive Officer, President and Director|
GenMark Diagnostics, Inc.
|Patrick J. Balthrop Sr.||Chief Executive Officer, President, Director, Member of Executive Committee and Member of Strategy & Development Committee|
|Michael K. McGarrity||Chief Executive Officer, President and Director|
|R. Bradley Gray||Chief Executive Officer, President and Director|
NanoString Technologies, Inc.
|Michael W. Hunkapiller Ph.D.||Executive Chairman, Chief Executive Officer, President and Member of Compensation Committee|
Pacific Biosciences of California, Inc.
|$1.00||Compensation as of Fiscal Year 2013.|